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Abstract. In Libo Kemkem (a district of Amhara region, Ethiopia), no cases of kala-azar had ever been reported
until 2005 when an outbreak occurred. Over one-third of those cases were children under 15 years of age. The aim of the
present study was to determine the prevalence of Leishmania infection in children aged 4–15 years. A cross-sectional
survey was conducted in 2009. Children participating in the survey were selected using a three-stage cluster sampling
method. A total of 386 children were included in the study. The overall prevalence of Leishmania infection (direct
agglutination test- and/or rK39 immunochromatographic test- and/or leishmanin skin test-positive subjects) in this
population was 1.02% (95% confidence interval = 0–4.54), and prevalence was higher in boys and children older than
12 years. Only one case of active disease was encountered. The results suggest that the conditions responsible for the
outbreak no longer reign. However, active surveillance remains necessary.
East Africa has suffered a marked increase in the number
of cases of visceral leishmaniasis (VL) or kala-azar over the
last two decades, probably because of a combination of demo-
graphic and climatic changes.1,2
The areas traditionally regarded as endemic for VL in
Ethiopia lie in the northwest (bordering Sudan) and south of
the country.3,4 Libo Kemkem district (wereda) is located in
the highlands of the Amhara region in northwestern Ethiopia
at an altitude of 1,800–2,000 m. According to year 2007 census,
population of Libo Kemkem was 198,374, and 69,388 people
were children between 4 and 15 years of age.5
No cases of kala-azar had ever been declared in this area
until 2005. Earlier, in 2004, the Amhara Regional Health
Bureau reported a fivefold increase in crude mortality rates in
the Libo Kemkem district, and this finding was attributed to an
outbreak of drug-resistant malaria. However, in May of 2005,
an outbreak of kala-azar caused by Leishmania donovani was
determined to be the culprit.6,7 The epidemiological back-
ground (a few cases over a 1-year period followed by an explo-
sive increase) was consistent with the rapid emergence of the
disease in a population with little pre-existing immunity.6 By
December of 2007, 2,543 patients with kala-azar had been
treated by Médecins sans Frontières.8 More than one-third of
the patients were children under 15 years of age, and a fatality
rate of over 3% was reported for this group.8 The rapid spread
of the disease between 2004 and 2007 suggested that transmis-
sion would not be easy to control.6 Before the Libo Kemkem
outbreak, there was no epidemiological surveillance system
for leishmaniasis in Ethiopia, making it difficult to determine
whether the epidemic between 2004 and 2007 was an outbreak
caused by a recent introduction of the parasite or as suggested
in the work by Herrero and others,8 the parasite being endemic
to the area but in low numbers.
The aim of the present study was to determine the preva-
lence of Leishmania infection in children aged 4–15 years
from Libo Kemkem 4 years after the outbreak.
A cross-sectional survey was conducted between May and
July of 2009 as part of the project Visceral Leishmaniasis and
Malnutrition in Amhara State, Ethiopia that was funded by
the UBS-Optimus Foundation; among its specific objectives
were aims to characterize nutritional, immunological, and
parasitological aspects in the school-aged child population
from this area. Sampling was undertaken as part of a multi-
staged cluster survey. The primary sampling units were ran-
domly selected subdistricts (kebeles) of Libo Kemkem that,
according to the records of Médecins sans Frontières-Greece
held at the Addis Zemen Health Center, had reported at least
one case of VL during the 2004–2007 epidemic. These areas
were selected taking into account their size according to a
recent census.5 The secondary sampling units were randomly
selected villages (gotts) in each of the selected subdistricts.
The tertiary sampling units were households randomly selected
from an updated census for each village. All children between
4 and 15 years of age residing in these households were tested.
A total of 386 children were included in the study.
Ethical clearance was obtained from the review boards of
the Instituto de Salud Carlos III, the Armauer Hansen
Research Institute, and the Ethiopian National Ethical Review
Committee. Parents/guardians gave written, informed consent
before the enrolment of their children in the study. For chil-
dren over 11 years of age, verbal assent was obtained in addi-
tion to the consent of their parents or guardians.
Each participant was clinically assessed by health profes-
sionals for any complaint of fever lasting longer than 2 weeks,
weight loss, and presence of splenomegaly and lymphade-
nopathy to determine the presence of any active infection. All
children were tested using the leishmanin skin test (LST), the
rK39 immunochromatographic test (rK39-ICT, Kalazar Detect
Rapid Test; InBios International Inc., Seattle, WA), and the
direct agglutination test (DAT) (ITMA-DAT/VL; Institute
of Tropical Medicine, Antwerp, Belgium). Sociodemographic
data were recorded using pretested questionnaires. The
rK39-ICT test was performed immediately after blood sam-
pling according to the manufacturer’s instructions. The DAT
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test was performed on blood-impregnated filter paper using
freeze-dried antigen. The screening method followed the
manufacturer’s protocol; titers of ³ 1:3,200 were deemed pos-
itive. Leishmanin skin testing was performed using L. major
antigen (Leishmanin batch 123–2; Pasteur Institute, Tehran,
Iran) as previously described.9,10
The overall prevalence of Leishmania infection (DAT-
and/or rK39-ICT- and/or LST-positive) in the population was
then calculated. Prevalence rates were expressed in percent-
ages with 95% confidence intervals (95% CIs). Stata v.10.1
software was used to perform all statistical analyses. Data
were weighted according to selection probabilities and ana-
lyzed using the Stata v.10.1 complex samples procedures,
which takes into account sample clustering.
Of 386 children, 199 (50.9%) were girls. The mean age of
the participants was 8.9 years (standard deviation [SD] =
3.03); 44.76% of the children were under 8 years of age, and
33.08% of the children were between 8 and 11 years.
Only one case of active VL was found, which returned
positive results for both rK39-ICT and DAT. Nine children
were DAT-positive only; four of these children had suffered
kala-azar previously. However, five children that previously
had VL showed negative results for both rK39-ICT and DAT.
None of the children returned a positive LST result. Post–
kala-azar dermal leishmaniasis (PKDL) or cutaneous leish-
maniasis cases were not found.
The overall prevalence of infection (DAT- and/or rk39-
positive) was 1.02% (95% CI = 0–4.54). The prevalence
among boys was higher (1.78%, 95% CI = 0–7.98 in boys;
0.3%, 95% CI = 0–1.31 in girls). The greatest prevalence was
recorded in children older than 12 years (2.56%, 95% CI =
0–10.54) followed by those children between 8 and 11 years
(0.82%, 95% CI = 0–3.53); the under 8 years subgroup showed
the lowest prevalence (0.49%, 95% CI = 0–2.59). However,
these prevalence values were not statistically different from
one another (Table 1).
To the best of our knowledge, these data are the first
Leishmania infection prevalence data for Libo Kemkem since
the 2004–2007 epidemic. Higher prevalence rates for similar
populations have, however, been reported for other regions
of Ethiopia.11,12
The permanence of leishmanin skin test reactivity is
thought to depend on latent infection and continuous expo-
sure to the biting of Leishmania-carrying sand flies11,13; a
decrease of these vectors and the establishment of a VL
treatment center after the 2004–2007 outbreak could have
contributed to the reduction of reservoirs, which might
explain the low prevalence of active cases in the present
study population.8 The vector decrease can only be possible
as a consequence of important environmental events,
because it happened in a short period of time after the out-
break. This finding highlights the need for both additional
entomological studies and establishment of a surveillance
system to avoid other catastrophic outbreaks in the study
area and neighboring places.
Some works report a natural conversion rate from positive
to negative of 14.8–9.3% in other settings in Ethiopia.14 Never-
theless, the absence of positive results is noteworthy, espe-
cially compared with previous results in the same age range
(23.6%),6 although in the latter study, rapid assessment by
convenience sampling was undertaken.
The present study also used DAT and rK39-ICT for
detecting infection, both of which reveal the presence of
anti-Leishmania antibodies appearing early after infection.
The combined use of these methods, which has performed
well in VL diagnosis in this area,15 yielded just a 1% preva-
lence for the 4- to 15-year-old age range. The prevalence of
Leishmania infection is expected to increase with age11; how-
ever, the presence of only one active case in the study popu-
lation and the low prevalence even among the older children
suggest a low prevalence for the general population. The
response to the 2004–2007 outbreak included the establish-
ment of centers where specific treatment could be received.
The clearance of patients’ infections would have diminished
the number of reservoirs, thus contributing to a reduction
in the seroprevalence rate for the whole population.
The discordances observed could be because of the differ-
ent immune responses detected by the different tests; LST
measures delayed type hypersensitivity, whereas serology
measures levels of anti-Leishmania antibodies. LST positivity
appears later after infection and seems to be a sign of protec-
tive immunity against VL, whereas seropositivity is consid-
ered a marker of more recent infection and has been related
to disease progression.16,17
The present results seem to indicate that the conditions
that provoked the kala-azar epidemic in the study region no
longer reign. The parasite may have been introduced by
migrant agricultural laborers who, returning to their villages
after completing seasonal work on the border of Sudan,18
acted as a reservoir of the causal parasite—a hypothesis put
forward at the time of the epidemic. However, the available
evidence indicates that the affected population was not made
up simply of migrant workers, and there is no evidence that
any such migration has ever ceased. This finding suggests
Table 1
Prevalence of Leishmania infection
Sample Prevalence of Leishmania infection (rK39-ICT and/or DAT-positive)
N* Percent† N* Percent† 95% CI† OR (95% CI) P
Overall 386 10 1.02 0–4.54
Sex
Girls 199 50.9 2 0.3 0–1.31 Reference
Boys 187 49.1 8 1.78 0–7.98 5.94 (0.38–93.84) 0.291‡
Age (years)
< 8 169 44.76 2 0.49 0–2.59 Reference
8–11 132 33.08 3 0.82 0–3.53 1.675 (0.1–29.12)
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that, as well as an increase in the size of the human reservoir,
some change in the vector population must have occurred.
Libo Kemkem lies at an altitude of 1,800–2,000 m, which is
beyond the altitude at which phlebotomes are normally
found. Changes in temperature (because of global warming)
or soil type (because of land use) could have been the reason
for either colonization of the Libo Kemkem area by sand fly
vectors or propagation of a native population, reaching high
enough levels to increase leishmaniasis transmission.19–21
New entomological studies should be carried out to elucidate
the role of sand fly vectors.
It should be noted, however, that the response to the out-
break included the establishment of centers where specific
treatment could be received. The clearance of patients’ infec-
tions would have led to a reduction in the seroprevalence rate.
Until 2004, no case of leishmaniasis had ever been reported
in Libo Kemkem. The very low prevalence in the study
population may suggest that the district may be experi-
encing a pre-epidemic status similar to the status seen before
the outbreak. Efforts to identify areas of high prevalence
and then focus control efforts in these places might be wiser
than blanket control of the entire district. However, the
doubts surrounding the reasons for the outbreak mean that
vigilance with respect to the impact of possible climate
changes should be considered; such changes might encourage
new outbreaks.
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